Search
Sharan Murugan
Feb 72 min read
USFDA Guidance: "Understanding the USFDA Notification Process for Discontinuance or Interruption in Manufacturing of Pharmaceutical Products"
Yesterday (06 February 2024) the U.S. Food and Drug Administration (FDA) Center for Drug Evaluation and Research and Center for Biologics...
28 views0 comments
Sharan Murugan
Nov 19, 20232 min read
USFDA MD Guidance: Notifying FDA of a Permanent Discontinuance, 506J Guidance & Computational Model
USFDA's Center for Devices and Radiological Health and Center for Biologics Evaluation and Research released multiple guidances related...
15 views0 comments
Sharan Murugan
Apr 5, 20232 min read
USFDA Guidance: Permanent Discontinuance or Interruption in Manufacturing of Finished Products &API
Today (o5 April 2023) USFDA's Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research released a draft...
63 views0 comments
Sharan Murugan
Mar 23, 20221 min read
Guidance on Renewal & Discontinuation of Authorisation on change of Status -Swiss Medic
This guidance document describes the rules that apply to the renewal or discontinuation of authorisation, how these rules are to be...
12 views0 comments